| Epigenetics of malignant melanoma B Moran, R Silva, AS Perry, WM Gallagher Seminars in cancer biology 51, 80-88, 2018 | 124 | 2018 |
| POLE somatic mutations in advanced colorectal cancer J Guerra, C Pinto, D Pinto, M Pinheiro, R Silva, A Peixoto, P Rocha, ... Cancer medicine 6 (12), 2966-2971, 2017 | 49 | 2017 |
| Longitudinal analysis of individual cfDNA methylome patterns in metastatic prostate cancer R Silva, B Moran, AM Baird, CJ O’Rourke, SP Finn, R McDermott, ... Clinical Epigenetics 13 (1), 168, 2021 | 18 | 2021 |
| Evaluating liquid biopsies for methylomic profiling of prostate cancer R Silva, B Moran, NM Russell, C Fahey, T Vlajnic, RP Manecksha, ... Epigenetics 15 (6-7), 715-727, 2020 | 16 | 2020 |
| Unveiling the epigenomic mechanisms of acquired platinum‐resistance in high‐grade serous ovarian cancer R Silva, K Glennon, M Metoudi, B Moran, S Salta, K Slattery, A Treacy, ... International Journal of Cancer 153 (1), 120-132, 2023 | 3 | 2023 |
| Investigating a clinically actionable BRAF mutation for monitoring low-grade serous ovarian cancer: A case report R Silva, B Moran, S Das, N Mulligan, M Doughty, A Treacy, K Sheahan, ... Case Reports in Women's Health 34, e00395, 2022 | 1 | 2022 |
| Deciphering epigenetic regulation of enhancers in high‐risk prostate cancer AV Tuzova, B Moran, NM Russell, S Das, F Delahaye, R Silva, C Barrett, ... Genes, Chromosomes and Cancer 63 (2), e23218, 2024 | | 2024 |
| EP004/# 741 DNA methylation landscape as a potential player in acquired-drug resistance in ovarian cancer R Silva, K Glennon, M Metoudi, B Moran, S Salta, K Slattery, A Treacy, ... International Journal of Gynecologic Cancer 32 (Suppl 3), 2022 | | 2022 |
| A family of mixture models for beta valued DNA methylation data K Majumdar, R Silva, AS Perry, RW Watson, A Rau, F Jaffrezic, ... arXiv preprint arXiv:2211.01938, 2022 | | 2022 |
| betaclust: a family of mixture models for beta valued DNA methylation data K Majumdar, R Silva, AS Perry, RW Watson, TB Murphy, IC Gormley arXiv preprint arXiv:2211.01938, 2022 | | 2022 |
| PROVE-PRostate and OVarian Epigenetics: investigating therapeutic resistance via cfDNA R Silva University College Dublin. School of Medicine, 2022 | | 2022 |
| Epigenetics and precision medicine in prostate cancer AC Jordan, M Prencipe, R Silva, WM Gallagher, AS Perry Epigenetics in Precision Medicine, 69-108, 2022 | | 2022 |
| 461 Investigating epigenomic involvement in acquired drug-resistance in high-grade serous ovarian cancer R Silva, M Metoudi, K Glennon, A Perry, D Brennan International Journal of Gynecologic Cancer 31 (Suppl 3), 2021 | | 2021 |
| Longitudinal analysis of personal DNA methylome patterns in metastatic prostate cancer RS Silva, BM Moran, WG Gallagher, DB Brennan, A Perry European Urology Open Science 19, e1563, 2020 | | 2020 |
| Abstract A34: Longitudinal analysis of personal DNA methylome patterns in metastatic prostate cancer R Silva, B Moran, WM Gallagher, DJ Brennan, AS Perry Clinical Cancer Research 26 (11_Supplement), A34-A34, 2020 | | 2020 |
| PO-045 Evaluating liquid biopsies for methylomic profiling of prostate cancer R Silva, B Moran, C Fahey, T Vlajinic, DJ Brennan, WM Gallagher, ... ESMO Open 3, A245, 2018 | | 2018 |
| Mutational Analysis of Kras and Nras in Metastatic Colorectal Cancer RO Silva PQDT-Global, 2014 | | 2014 |
Antoinette PerryUniversity College DublinVerified email at ucd.ie
